NASDAQ
Amplia Therapeutics Limited (INNMF) has a free cash flow growth of 86.31% as of Friday, May 29, 2026. This represents a 199.77% increase compared to its 12-month average of -86.51%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.